Population of Americans with Alzheimer's will more than double by 2060, study shows

December 7, 2017
Ron Brookmeyer. Credit: UCLA Fielding School of Public Health

About 15 million Americans will have either Alzheimer's dementia or mild cognitive impairment by 2060, up from approximately 6.08 million this year, according to a new study by researchers at the UCLA Fielding School of Public Health.

The findings highlight the need to develop measures that could slow the progression of the disease in people who have indications of neuropathological changes that could eventually lead to Alzheimer's dementia, said Ron Brookmeyer, professor of biostatistics at the UCLA Fielding School of Public Health and the study's lead author. The country's population is aging and with it comes a growing number of people with Alzheimer's disease.

The study was published today in the peer-reviewed Alzheimer's and Dementia: The Journal of the Alzheimer's Association. The study is the first of its kind that has estimated the numbers of Americans with preclinical Alzheimer's disease or .

"There are about 47 million people in the U.S. today who have some evidence of preclinical Alzheimer's, which means they have either a build-up of protein fragments called beta-amyloid or neurodegeneration of the brain but don't yet have symptoms," Brookmeyer said. "Many of them will not progress to Alzheimer's dementia in their lifetimes. We need to have improved methods to identify which persons will progress to clinical symptoms, and develop interventions for them that could slow the progression of the disease, if not stop it all together."

The researchers examined the largest studies available on rates of progression of Alzheimer's disease and used that information in a computer model they built that took into account the aging of the U.S population. The model projected the numbers of people in preclinical and clinical disease states.

They found that by 2060 about 5.7 million Americans will have mild cognitive impairment and another 9.3 million will have dementia due to Alzheimer's. Of the latter group, about 4 million Americans will need an intensive level of care similar to that provided by nursing homes. Mild cognitive impairment is an intermediate clinical stage that does not yet meet the threshold for dementia. Brookmeyer estimates that today about 2.4 million Americans are living with mild cognitive impairment due to Alzheimer's disease.

"Estimates by disease state and severity are important because the resources needed to care for patients vary so much over the course of the illness," Brookmeyer said.

There are some sources of uncertainty in the findings. Participants in the studies the researchers examined may not represent all demographics. Also, there are other types of dementia, such as vascular , that were not examined but could have an impact on these numbers.

Explore further: Being unaware of memory loss predicts Alzheimer's disease, new study shows

Related Stories

Being unaware of memory loss predicts Alzheimer's disease, new study shows

October 10, 2017
While memory loss is an early symptom of Alzheimer's disease, its presence doesn't mean a person will develop dementia. A new study at the Centre for Addiction and Mental Health (CAMH) has found a clinically useful way to ...

Hearing loss linked to early memory and thinking problems

July 17, 2017
Researchers at the Alzheimer's Association International Conference 2017 have suggested that people with a family history of Alzheimer's disease who experience hearing loss, are more likely to also experience a decline in ...

Personality changes don't precede clinical onset of Alzheimer's, study shows

September 21, 2017
For years, scientists and physicians have been debating whether personality and behavior changes might appear prior to the onset of Alzheimer's disease and related dementias.

Less fluent speech could be a sign of early memory problems

July 17, 2017
Researchers in the US have found that people with very mild memory and thinking problems also show changes in their everyday speech.

Can poor sleep boost odds for Alzheimer's?

July 18, 2017
(HealthDay)— Breathing problems during sleep may signal an increased risk for Alzheimer's disease, a trio of studies suggests.

Alzheimer's drug prescribed 'off-label' for mild cognitive impairment could pose risk for some

February 24, 2017
Donepezil, a medication that is approved to treat people with Alzheimer's disease, should not be prescribed for people with mild cognitive impairment without a genetic test. UCLA School of Nursing researchers discovered that ...

Recommended for you

Canola oil linked to worsened memory and learning ability in Alzheimer's

December 7, 2017
Canola oil is one of the most widely consumed vegetable oils in the world, yet surprisingly little is known about its effects on health. Now, a new study published online December 7 in the journal Scientific Reports by researchers ...

Genetics study suggests that education reduces risk of Alzheimer's disease

December 7, 2017
The theory that education protects against Alzheimer's disease has been given further weight by new research from the University of Cambridge, funded by the European Union. The study is published today in the BMJ.

Healthy mitochondria could stop Alzheimer's

December 6, 2017
Alzheimer's disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called ...

Alzheimer's damage in mice reduced with compound that targets APOE gene

December 6, 2017
People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease.

Lithium in water associated with slower rate of Alzheimer's disease deaths

December 5, 2017
Rates of diabetes and obesity, which are important risk factors for Alzheimer's disease, also decrease if there is a particular amount of lithium in the water, says the study, published recently in the Journal of Alzheimer's ...

Hyperbaric oxygen therapy may alleviate symptoms of Alzheimer's Disease

December 5, 2017
A new Tel Aviv University study reveals that hyperbaric oxygen treatments may ameliorate symptoms experienced by patients with Alzheimer's disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.